pharmaceuticals

The benefits of pharmacy benefit manager (PBM) spending remained murky for lawmakers with the Health Care Cost Oversight Task Force, who spent hours listening to presentations about PBM oversight and contracting.

Baxter International Inc. BioPharma Solutions was sold to Advent International and Warbug Pincus in May. As part of the $4.25 billion deal, Baxter’s BioPharma Solutions will be renamed Simtra BioPharma Solutions.

The FTC released a statement supporting the cancellation, saying it “ensures that critical reproductive health markets remain competitive.”

Lobbying and lawsuits from the drug industry could ultimately limit how much power Medicare will have to negotiate drug prices and save money.

A Supreme Court case this summer briefly thrust the little known but highly controversial program into the spotlight. In 2018, the federal government cut payments to hospitals in the program, and a group of hospitals and trade associations sued.